News

The study, which will enroll 44 children from the US, Chile and Mexico, aims to decrease luteinizing hormone (LH) to prepubertal levels at month 6 (Day 169) in

FDA after consultations with the Genzyme has asked it to modify the data sets presentation to enable the agency to process the application. The FDA has not requested

Three month, multi-site, double blind, randomized, placebo-controlled, parallel-group trial is designed to assess the safety, tolerability and potential effect of anatabine in subjects with Alzheimer’s disease. Previous tissue

Re-Load Male Enhancement is designed for men who want to improve their performance, while Re-Load 7 Hour Energy, made up of herbs, vitamins and energy producing D-Ribose, has

The company’s antiviral drugs are designed to target the function of capsid, a viral protein required for the replication and transmission of the virus particle. The important aspects

Based on an ongoing assessment of patients in a Phase II study that the company voluntarily suspended on 1 August 2012, the decision was taken and the FDA

Lidocaine is an amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses. In

eHealth Saskatchewan is involved in coordinating, operating and maintaining other selected information technology systems in the province of Saskatchewan, Canada. Under the three-year contract, SAIC Canada will provide

FV-100 is an orally available nucleoside analogue, at present being developed for the treatment of shingles, a painful skin rash caused by reactivation of the varicella zoster virus,